<DOC>
	<DOC>NCT00035009</DOC>
	<brief_summary>A clinical study to determine the efficacy and safety of MK0869 in the treatment of depression</brief_summary>
	<brief_title>Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)</brief_title>
	<detailed_description>The duration of treatment is 8 weeks.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>Major Depressive Disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>